Notes Payable (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2025 |
Dec. 31, 2024 |
| Notes Payable [Abstract] |
|
|
| Schedule of Convertible Notes |
The balance of the convertible notes as of
March 31, 2025, and December 31, 2024, is as follows:
| | |
March 31, | | |
December 31, | |
| | |
2025 | | |
2024 | |
| Convertible notes payable | |
$ | 43,138 | | |
$ | 43,138 | |
| Less: Discount | |
| - | | |
| - | |
| Convertible notes payable, net | |
$ | 43,138 | | |
$ | 43,138 | |
|
The balance of the convertible notes as of
December 31, 2024, and December 31, 2023, is as follows:
| | |
December 31,
| | |
December 31,
| |
| | |
2024 | | |
2023 | |
| Convertible notes payable | |
$ | 43,138 | | |
$ | 44,939 | |
| Less: Discount | |
| - | | |
| 9,916 | |
| Convertible notes payable, net | |
$ | 43,138 | | |
$ | 35,023 | |
|
| Schedule of Promissory Notes |
The balance of the promissory notes as of
March 31, 2025, and December 31, 2024, is as follows:
| | |
March 31, | | |
December 31, | |
| | |
2025 | | |
2024 | |
| Promissory notes payable | |
$ | 19,722,931 | | |
$ | 19,722,931 | |
| Promissory notes payable-related party | |
| 7,800 | | |
| 7,800 | |
| Promissory notes payable, net | |
$ | 19,730,731 | | |
$ | 19,730,731 | |
|
The balance of the promissory as of December
31, 2024, and December 31, 2023, is as follows:
| | |
December 31, | | |
December 31, | |
| | |
2024 | | |
2023 | |
| Promissory notes payable | |
$ | 19,730,731 | | |
$ | 19,730,731 | |
| Less: Discount | |
| - | | |
| 2,100,966 | |
| Less: Deferred finance costs | |
| - | | |
| 15,798 | |
| Promissory notes payable, net | |
$ | 19,730,731 | | |
$ | 17,613,966 | |
|
| Schedule of Fair Values of the Embedded Convertible Notes Derivatives and Tainted Convertible Notes Using the Lattice Valuation |
The Company determined the fair values of
the embedded convertible notes derivatives and tainted convertible notes using the lattice valuation model with the following assumptions:
| | |
March 31, | |
| | |
2025 | |
| Common stock issuable | |
| 182,438 | |
| Market value of common stock on measurement date | |
$ | 0.032 | |
| Adjusted exercise price | |
$ | 0.06 | |
| Risk free interest rate | |
| 4.08 | % |
| Instrument lives in years | |
| 0.50 Year | |
| Expected volatility | |
| 271.10 | % |
| Expected dividend yields | |
| None | |
|
The Company determined the fair values of
the embedded convertible notes derivatives and tainted convertible notes using the lattice valuation model with the following assumptions:
| | |
December 31, | |
| | |
2024 | |
| Common stock issuable | |
| 180,346 | |
| Market value of common stock on measurement date | |
$ | 0.026 | |
| Adjusted exercise price | |
$ | 0.06 | |
| Risk free interest rate | |
| 4.26 | % |
| Instrument lives in years | |
| 0.25 Year | |
| Expected volatility | |
| 7.80 | % |
| Expected dividend yields | |
| None | |
|
| Schedule of Fair Value of the Derivative Liability |
The balance of the fair value of the derivative
liability as of March 31, 2025, and December 31, 2024, is as follows:
| Balance at December 31, 2023 | |
$ | 2,146 | |
| Additions | |
| - | |
| Fair value loss | |
| 2,543 | |
| Conversions | |
| - | |
| Balance at December 31, 2024 | |
| 4,689 | |
| Additions | |
| - | |
| Fair value gain | |
| 1,149 | |
| Conversions | |
| - | |
| Balance at March 31, 2025 | |
$ | 5,838 | |
|
The balance of the fair value of the derivative
liability as of December 31, 2024, and December 31, 2023, is as follows:
| Balance at December 31, 2022 | |
$ | 6,944 | |
| Additions | |
| - | |
| Fair value loss | |
| (3,450 | ) |
| Conversions | |
| (1,348 | |
| Balance at December 31, 2023 | |
| 2,146 | |
| Additions | |
| - | |
| Fair value gain | |
| 2,543 | |
| Conversions | |
| - | |
| Balance at December 31, 2024 | |
$ | 4,689 | |
|